‘Game-Changing’ Immunotherapy Cancer Drug Boosts Survival Rates Five-Fold
11th September 2019
Patients with advanced lung cancer were far more likely to be alive after five years, compared with those given standard chemotherapy.
The immunotherapy drug nivolumab, which is used for several cancers, works by blocking a protein that stops the immune system attacking cancer cells.
September 11th, 2019 at 07:57
Having done chemo, I hope and pray that immunotherapy will quickly move chemo onto the same history shelf as blood-letting and leeches.